Literature DB >> 7686142

Vitronectin secretion by hepatic and non-hepatic human cancer cells.

H Yasumitsu1, N Seo, E Misugi, H Morita, K Miyazaki, M Umeda.   

Abstract

Thirty-eight human cancer cell lines and subclones derived from 12 different organs were screened for vitronectin secretion in their culture media. By immunoblotting analysis we detected high secretion by three out of five hepatoma cell lines tested but no secretion by the others. In addition, significant secretion was observed in seven non-hepatic cancer cell lines and subclones derived from the cervix, lung, and pancreas. These vitronectin-secreting cells included PLC/PRF/5, HuH-6 #5, HuH-7, HeLa S3, HeLa.P3 #2, #3, #6, #8, A549, and MIAPaCa-2. The results were further confirmed by quantitative analysis using sandwich enzyme-linked immunoassay, and activity analysis of cell attachment promotion on Western blotted filters.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686142     DOI: 10.1007/bf02633989

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  26 in total

Review 1.  Vitronectin.

Authors:  B R Tomasini; D F Mosher
Journal:  Prog Hemost Thromb       Date:  1991

2.  Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells.

Authors:  C L Gladson; D A Cheresh
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Diversities in animal vitronectins. Differences in molecular weight, immunoreactivity and carbohydrate chains.

Authors:  H Kitagaki-Ogawa; T Yatohgo; M Izumi; M Hayashi; H Kashiwagi; I Matsumoto; N Seno
Journal:  Biochim Biophys Acta       Date:  1990-01-29

5.  Electroblotting of multiple gels: a simple apparatus without buffer tank for rapid transfer of proteins from polyacrylamide to nitrocellulose.

Authors:  J Kyhse-Andersen
Journal:  J Biochem Biophys Methods       Date:  1984-12

6.  Detection of vitronectin mRNA in tissues and cells of the mouse.

Authors:  D Seiffert; M Keeton; Y Eguchi; M Sawdey; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

7.  Establishment and some biological characteristics of human hepatoma cell lines.

Authors:  I Dor; M Namba; J Sato
Journal:  Gan       Date:  1975-08

8.  A monoclonal antibody (LYP18) directed against the blood platelet glycoprotein IIb/IIIa complex inhibits human melanoma growth in vivo.

Authors:  H Boukerche; O Berthier-Vergnes; M Bailly; J F Doré; L L Leung; J L McGregor
Journal:  Blood       Date:  1989-08-15       Impact factor: 22.113

9.  Vitronectin production by human yolk sac carcinoma cells resembling parietal endoderm.

Authors:  S Cooper; M F Pera
Journal:  Development       Date:  1988-12       Impact factor: 6.868

10.  Serum-derived vitronectin influences the pericellular distribution of type 1 plasminogen activator inhibitor.

Authors:  D Seiffert; N N Wagner; D J Loskutoff
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more
  3 in total

1.  Inhibition of the Membrane Attack Complex by Dengue Virus NS1 through Interaction with Vitronectin and Terminal Complement Proteins.

Authors:  Jonas Nascimento Conde; Emiliana Mandarano da Silva; Diego Allonso; Diego Rodrigues Coelho; Iamara da Silva Andrade; Luciano Neves de Medeiros; Joice Lima Menezes; Angela Silva Barbosa; Ronaldo Mohana-Borges
Journal:  J Virol       Date:  2016-10-14       Impact factor: 5.103

Review 2.  Regulation of complement and modulation of its activity in monoclonal antibody therapy of cancer.

Authors:  Saskia Meyer; Jeanette H W Leusen; Peter Boross
Journal:  MAbs       Date:  2014-10-30       Impact factor: 5.857

3.  Characterization of matrix-degrading proteinases and their inhibitors secreted by human gynecological carcinoma cells.

Authors:  E Miyagi; H Yasumitsu; F Hirahara; H Minaguchi; N Koshikawa; K Miyazaki; M Umeda
Journal:  Jpn J Cancer Res       Date:  1995-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.